2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer

Affiliation auteurs!!!! Error affiliation !!!!
Titre2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer
Type de publicationJournal Article
Year of Publication2015
AuteursEberhardt W.EE, De Ruysscher D., Weder W., Le Pechoux C., De Leyn P., Hoffmann H., Westeel V., Stahel R., Felip E., Peters S.
JournalANNALS OF ONCOLOGY
Volume26
Pagination1573-1588
Date PublishedAUG
Type of ArticleArticle
ISSN0923-7534
Mots-clésESMO, locally advanced, Non-small-cell lung cancer, Recommendations, stage III
Résumé

To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO Consensus Conference on Lung Cancer was held on 11-12 May 2013 in Lugano. A total of 35 experts met to address several questions on non-small-cell lung cancer (NSCLC) in each of four areas: pathology and molecular biomarkers, first-line/second and further lines of treatment in advanced disease, early-stage disease and locally advanced disease. For each question, recommendations were made including reference to the grade of recommendation and level of evidence. This consensus paper focuses on locally advanced disease.
DOI10.1093/annonc/mdv187